Objective: To quantify screening rate for gestational diabetes mellitus and completion of oral glucose tolerance test in rural and remote Western Australia. Design and participants: Retrospective audit of 551 antenatal records from women of 16 years and older without pre-existing diabetes and with singleton pregnancies delivered in 2013. Main outcome measures: Number of women recorded screened for gestational diabetes mellitus in second or third trimester using oral glucose tolerance test or other tests; gestational diabetes mellitus rate. Results: Only 278 (50.5%) women were screened with oral glucose tolerance test; 113 (20.5%) had no record of any screening related to gestational diabetes mellitus. In a nested mixed-effects logistic regression model, women with a previous gestational diabetes mellitus diagnosis, two or more risk factors (excluding ethnicity) or high-risk gestational diabetes mellitus ethnicity other than Australian Aboriginal were more likely to be screened, while Australian Aboriginal women were less likely to be screened with oral glucose tolerance test. Clinicians reported patient and clinician factors and logistical difficulties as reasons for the oral glucose tolerance test not being completed at their site. Of those screened with oral glucose tolerance test, a high rate of gestational diabetes mellitus was diagnosed (14.7% versus Western Australia state-wide average of 7.4%). Conclusion: Adherence to oral glucose tolerance test screening in rural Western Australia is inadequate for effective screening for gestational diabetes mellitus. Screening was not acceptable or available for a significant proportion of women at risk. Efforts to improve oral glucose tolerance test adherence and exploration of alternative gestational diabetes mellitus screening strategies are required.
Introduction
The prevalence of diabetes, including gestational diabetes mellitus (GDM), has risen in recent decades. 1 In Western Australia (WA), GDM has risen from 2.3% of all pregnancies in 1993 2 to 7.4% in 2013. 3 Higher rates of GDM have been reported in Indigenous populations globally. 4 In 2005-2006, age-standardised incidence in Australian Aboriginal and Torres Strait women was 1.5 times that of other Australian women. 5 Gestational diabetes mellitus (GDM) is associated with adverse neonatal and maternal outcomes, including macrosomia, neonatal hypoglycaemia, respiratory distress, higher rates of preterm delivery and delivery by Caesarean. 6 Children of mothers with GDM are at greater risk of impaired glucose tolerance and obesity in later life. 7 The risk of women with GDM developing type 2 diabetes is seven times greater than in women without GDM.
Following the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study, 9 the oral glucose tolerance test (OGTT) is internationally recognised as the gold standard for diagnosing GDM. In the HAPO study, involving 25 505 women who were tested with OGTT and glycated haemoglobin (HbA 1c ) at 24-28 weeks' gestation, it was found OGTT to be superior to HbA 1c in predicting some of the adverse primary (e.g. macrosomia, cord C-peptide levels) and secondary (e.g. primary Caesarean section, sum of neonatal skinfolds) outcomes measured. 10 The impact of HAPO is that recommended screening for GDM has shifted from risk group identification to universal diagnostic testing with OGTT. 11 Prior to this, in Australia, women were screened with a glucose challenge test (GCT) and referred for OGTT if measuring over a predetermined threshold. The transition from screening with GCT to OGTT for all pregnancies has proceeded on a state-by-state basis in Australia, with universal OGTT implemented in WA in April 2012.
Anecdotally, clinicians report a significant number of antenatal patients failing to complete the OGTT. In view of limited published data on screening rates for GDM since universal screening was introduced, this study aimed to document OGTT testing in rural WA and any alternative tests used to screen for GDM.
Methods
Paper and electronic medical records of women receiving antenatal care at 12 clinical sites around regional, rural and remote WA were retrospectively audited between 5 August 2014 and 3 November 2015. Clinical sites were selected based on where members of the research team had access to antenatal records as part of their normal clinical duties (e.g. GP obstetricians or clinical staff working at birthing hospitals, Aboriginal Community Controlled Health Services or private GP obstetric clinics). Clinical sites providing the majority of antenatal care were categorised by the current remoteness index for Australia, the Modified Monash Model (MMM). 12 Women in this convenience sample were included if: aged 16 years or more at delivery; no documented pre-existing diabetes; singleton pregnancy; and delivered in rural WA in 2013. The GDM was primarily diagnosed using accepted criteria at the time (OGTT:
). The GDM had also been diagnosed by treating clinicians based on other criteria. These diagnoses were recorded as indicated in patients' notes. The test used to diagnose GDM was recorded (OGTT, fasting and random blood glucose, HbA 1c and GCT). Risk factors recorded included previous GDM, ethnicity, maternal age, family history of diabetes or GDM, obesity, hypertension prior to 20 weeks, previous macrosomia, history of unexplained stillbirth, previous baby with congenital abnormalities and polycystic ovarian syndrome. Clinicians involved in the audit were requested to reflect on screening practice, including review of clinical notes for evidence as to why the OGTT was not completed and other tests were used instead.
Statistical analysis
Data were imported into Stata 13 (StataCorp, College Station, TX, USA). Differences in characteristics between Aboriginal and non-Aboriginal women were compared using v 2 tests for categorical data and Mann-Whitney tests for continuous non-parametric data. As the first step, logistic regression models were created using a backward step-wise approach to identify factors associated with: (i) OGTT screening; and (ii) those diagnosed with GDM. Following this, a What is already known on this subject:
• Gestational diabetes incidence is increasing in Australia.
• The key to minimising its impact is early screening and active management through pregnancy.
• The current recommended screening test has a widely varying completion rate when measured in different settings internationally (30-91%).
What this study adds:
• Screening for gestational diabetes mellitus with the recommended oral glucose tolerance test was only recorded in half the population audited.
• Gestational diabetes mellitus was diagnosed twice as frequently in those completing the oral glucose tolerance test in this study, compared with the whole of Western Australia for the same year (14.7% versus 7.4%).
• The study highlights the need for better processes to ensure oral glucose tolerance test screening occurs and further study into alternative screening strategies that could reduce the number of oral glucose tolerance tests required without compromising diagnosis.
nested mixed-effect logistic regression model with antenatal care sites (n = 29), included as a random effect, was fitted for the screening outcome. Diagnosis follows directly from the OGTT screening result and is independent of subject or site. For all models, P < 0.05 was defined as statistically significant. 
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Results
Five-hundred-and-fifty-one women (39.0% Australian Aboriginal; 8.3% other high-risk ethnicities) were audited, representing 7.7% of 7198 births in rural WA and 12.4% of 1739 births to Australian Aboriginal women in WA in 2013. 3 All women audited reached 24 weeks' gestation between 5 August 2012 and 25 October 2013. The audit sampled 12 clinics from five geographical regions (Table 1) .
The Aboriginal women were significantly younger and more had preterm deliveries, compared to nonAboriginal (Table 2) . After excluding high-risk ethnicity as a risk factor, Australian Aboriginal women had significantly more risk factors for GDM than nonAboriginal women (47.0% versus 34.8%; P = 0.004; Table 2 ). Most (98.6%) Aboriginal women audited received the majority of antenatal care from health services located in MMM3, MMM6 and MMM7. Most non-(92.2%) Aboriginal women audited received their care in MMM2 and MMM3 (Table 2) .
Only 278 (50.5%) women were recorded as screened appropriately, according to guidelines at the time, using OGTT. One-hundred-and-thirteen (20.5%) women had no screening for GDM recorded ( Table 3) . The lowest and highest OGTT screening rates by any health service with at least 20 audited records were 29.2% (7 of 24) and 72.5% (74 of 102; Kalgoorlie), respectively. Alternative tests related to GDM screening were GCT (n = 101), random plasma glucose (n = 87), HbA 1c (n = 42) and fasting plasma glucose (n = 20).
In the nested mixed-effects logistic regression model, the likelihood of being screened with OGTT was higher in women with a previous GDM diagnosis (odds ratio, OR, 4.2; 95% confidence interval, CI, 1.5-12.3; P = 0.008), two or more risk factors, excluding ethnicity (OR, 2.3; 95% confidence interval, CI, 1.4-3.7; P = 0.001), or high-risk GDM ethnicity other than Australian Aboriginal (OR, 3.0; 95% CI, 1.8-5.0; P < 0.001). The likelihood of being screened with OGTT was lower in Aboriginal women (OR, 0.45; 95% CI, 0.26-0.79; P = 0.005). This was not independently influenced by the time since introduction of universal screening, remoteness classification or any other GDM risk factor recorded. Clinicians at each audit site reported that patient and clinician factors and logistical difficulties were the most likely reasons that the OGTT was not completed at their site (Table 4) . Of 278 women screened with OGTT, 41 (14.7%) were diagnosed with GDM (Table 3 ). In the logistic regression model, women were more likely to be diagnosed with GDM if they previously had GDM (OR, 7.7; 95% CI, 2.7-22.3; P < 0.001) or high-risk GDM ethnicity other than Australian Aboriginal (OR, 2.7; 95% CI, 1.1-6.7; P = 0.035). This was not independently influenced by the time since introduction of universal screening, remoteness classification or any other GDM risk factor recorded. There was also no difference in diagnosis rates between Australian Aboriginal women and women who had a low-risk GDM ethnicity (OR, 1.2; 95% CI, 0.52-2.6; P = 0.7). 
Discussion
This is the first report of completion rates for OGTT as a universal screening test for GDM in rural Australia. Recommended screening with OGTT failed to occur for half the pregnant women audited. This falls within the lower end of the range of OGTT screening rates reported in Europe (30-91%). [14] [15] [16] It also falls between other Australian universal screening programs where the test is not simple, such as cervical cancer (70% of eligible women within 3 years) 17 and bowel cancer screening (37% in 2013-2014) . 18 In Northern Australia, Pap smear screening rates were half the national rate and remoteness of community was associated with lower participation rates. 19 Screening for GDM with OGTT fits some of the requirements for a high-quality screening program 20 : GDM is an important health issue with a well-understood natural history; there is an effective treatment; OGTT has high sensitivity and good specificity; and benefits of screening outweigh risks. Other requirements, such as whether OGTT is a suitable and acceptable test, if detection is early enough and costeffectiveness compared with alternatives, have not yet been well documented.
In terms of acceptability, the OGTT is difficult for many pregnant women to complete. Side-effects, including nausea, vomiting, bloating, diarrhoea, sweating, dizziness and headache, affect up to 38%. 21, 22 Apart from these studies, there is little or no discussion of acceptability of OGTT screening in the literature. While this study was not designed to answer the question of why so few women were screened with the OGTT, reflection by clinical investigators in the different rural sites audited indicates that this is likely due to a range of factors. Both clinician and patient factors may be important and this warrants further research.
One reason for the failure to complete antenatal screening tests might be that the barriers to accessing health services in rural and remote areas, such as distance to clinics, poor health literacy and socioeconomic disadvantage, deter attendance for routine tests that are relatively easily done in urban settings. If this was the case then, all testing would suffer. The data presented here do not suggest that women in remote areas are less likely to complete antenatal care. On the contrary, remote sites with a low rate of OGTT completion had a high rate of alternative testing and a higher overall rate of testing. For GDM to be successfully diagnosed and treated, screening is the first and most important step. If half the population is not screened effectively, many cases will be missed. This is particularly important as this study also highlights a higher rate of diagnosis of GDM in those screened with OGTT than recorded state-wide in the same time period (14.7% versus 7.4% 3 ). In the context of ongoing increasing prevalence of diabetes and the known complications of GDM for mothers and babies, this gap in current screening is disturbing.
This study was carried out across diverse settings but might not be fully representative of rural WA. Sites were selected opportunistically and sites from MMM4 and MMM5 are not well represented in our sample group. Of the seven geographical regions identified by WACHS, we have sampled five. The Pilbara and Wheatbelt were not represented.
However, even the best location only reached 72.5%, which is substantially less than is recorded for other routine screening in pregnancy (ultrasound, 97.4% in 2013) 3 and less than ideal screening for this common high-risk condition. A file review depends on the completeness of records. Tests might have been done but not recorded in the notes used for this study.
To minimise this effect, we used the most complete notes available in each clinical setting and where possible cross-checked with other sources of medical information, such as discharge summaries from hospitals. However, despite the best efforts, some test results might not have been in the notes and coverage underestimated.
The audit period might have been too soon for the adoption of new guidelines to become established. However, in the multivariate analysis, time since the introduction of universal screening did not affect the likelihood of being screened with OGTT. Requiring a screening test is not sufficient to effect change. Real-world implementation of new programs is a complex, fragmented and ongoing process requiring detailed planning. 23, 24 High staff turnover, institutional amnesia and delays need to be factored in. Implementation takes time, effort and resources and requires a multidimensional and multidisciplinary approach that involves extensive consultation with heath care providers and patients. Continuous quality improvement processes need to be built into the implementation of new programs and adequately resourced. 23 While the OGTT is the gold standard for diagnosing GDM, it has failed as a screening test in rural WA. Strategies to improve coverage in rural and remote areas need to be implemented. Given the problems with OGTT as a screening test, we suggest it is time to also explore simpler tests to reduce the number of OGTTs required. assisted in completing this project and the health services that agreed to participate.
